5th October 2015, Nemaura Medical Inc. (OTC BB: NMRD),(“Nemaura”), a medical device company developing the sugarBEAT® CGM System as...
Nemaura Medical Inc. (OTC BB: NMRD),(“Nemaura”), a medical device company developing the sugarBEAT® CGM System as a non-invasive, wireless...
Nemaura Medical Inc. (OTC BB: NMRD), a leading developer of minimally-invasive transdermal diagnostic technologies, announced today that Dr. D...
Nemaura Medical announces licensing deal with DB Pharma (Jersey) Ltd., for its unique non-invasive wireless continuous glucose monitoring Watch...